FDA Issues Emergency Use Authorization for Another Experimental COVID-19 Vaccine

English
0
No votes yet

The FDA today issued an emergency use authorization (EUA) for Janssen Biotech’s adenovirus experimental COVID-19 vaccine.

Janssen Biotech, Inc., is a subsidiary of the Johnson and Johnson multi-national corporation, which has paid out BILLIONS in criminal settlements, which is ongoing due to the opioid crisis. You can read their criminal rap sheet here.

The Johnson and Johnson experimental COVID vaccine is not an mRNA vaccine, it is an “adenovirus” vaccine, but like mRNA vaccines, there are currently no approved adenovirus vaccines in the market, although the military has used experimental adenovirus vaccines that are not FDA approved.

So by getting the FDA to issue an EUA, Johnson and Johnson can now test their experimental vaccine on the public as part of their Phase 3 trials.

https://vaccineimpact.com/2021/fda-issues-emergency-use-authorization-for-another-experimental-covid-19-vaccine/